• Protease Inhibitor Cocktail: Precision in Protein Extraction

  2026-05-24

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) empowers researchers to safeguard protein integrity during extraction, even in cation-sensitive assays. Its tailored, EDTA-free formulation is indispensable for advanced post-translational modification studies and complex immunoprecipitation workflows.

• Valemetostat in Relapsed/Refractory NHL: Phase 1 Efficacy an

  2026-05-23

  This multicentre phase 1 study establishes the clinical activity and manageable safety profile of valemetostat, a dual EZH2/EZH1 inhibitor, in relapsed or refractory non-Hodgkin lymphoma. The research provides foundational data on optimal dosing and highlights epigenetic targeting as a viable strategy in lymphoma therapy.

• HotStart 2X Green qPCR Master Mix: Precision in Gene Quantif

  2026-05-22

  HotStart™ 2X Green qPCR Master Mix enables researchers to achieve highly specific, reproducible nucleic acid quantification, even with complex or low-abundance targets. Its antibody-mediated hot-start Taq polymerase and optimized SYBR Green formulation streamline workflows for gene expression analysis, RNA-seq validation, and challenging clinical assays.

• FITC Goat Anti-Rabbit IgG (H+L): Quantitative Fluorescence M

  2026-05-22

  Explore how the FITC Goat Anti-Rabbit IgG (H+L) Antibody revolutionizes quantitative immunofluorescence by enabling ultra-sensitive, reproducible assays. This article delivers a scientific deep dive into its mechanisms, unique advantages, and evidence-based protocol optimization.

• Circ_0001944 Regulates FXR/TLR4 and Ferroptosis in NiONP Fib

  2026-05-21

  This study uncovers how hsa_circ_0001944 mitigates nickel oxide nanoparticle-induced collagen deposition in hepatic stellate cells by regulating the FXR/TLR4 signaling pathway and ferroptosis. The findings clarify molecular links between non-coding RNA, metabolic nuclear receptor signaling, and regulated cell death in liver fibrosis, providing a mechanistic basis for FXR agonist–based research strategies.

• SAG: Strategic Hedgehog Pathway Activation for CNS Regenerat

  2026-05-21

  This article explores Smoothened Agonist (SAG) as a next-generation tool for translational researchers aiming to modulate the Hedgehog pathway across neuroregeneration and immune models. We dissect mechanistic insights, highlight sex-dependent immune modulation, and deliver strategic guidance for designing robust, clinically relevant studies—bridging recent reference breakthroughs with actionable experimental protocols.

• Ciclesonide in Experimental Asthma: Protocols & Performance

  2026-05-20

  Harness Ciclesonide’s unique prodrug activation and potent anti-inflammatory action to elevate your asthma and allergic rhinitis research. This article details reproducible workflows, troubleshooting strategies, and practical advances from ERAD-hijacking technology, with protocol enhancements and data-driven tips to maximize the reliability of your results.

• Multi-Omics Reveals ARID1A-Driven Resistance in Melanoma

  2026-05-20

  This study uses integrative multi-omics to unravel the molecular networks underlying resistance to BRAF/MAPK inhibitors in melanoma, especially in the context of ARID1A loss. The findings provide a detailed roadmap for understanding adaptive and acquired resistance, highlighting actionable nodes within the MAPK and immune pathways.

• Ruxolitinib Induces Apoptosis via DRP1 Inhibition in ATC

  2026-05-19

  This study reveals that Ruxolitinib phosphate (INCB018424) triggers both apoptosis and GSDME-dependent pyroptosis in anaplastic thyroid carcinoma (ATC) by transcriptionally inhibiting DRP1-mediated mitochondrial fission. The findings establish a novel mechanistic link between JAK1/2-STAT3 pathway inhibition and mitochondrial dynamics, highlighting new therapeutic angles for aggressive thyroid cancers.

• HyperScribe T7 High Yield Cy3 RNA Labeling Kit: Advanced RNA

  2026-05-19

  Harness the HyperScribe T7 High Yield Cy3 RNA Labeling Kit for sensitive, customizable fluorescent RNA probe synthesis. This guide details stepwise workflows, troubleshooting, and cutting-edge applications, empowering researchers to achieve robust detection in in situ hybridization and Northern blot assays.

• Ordered DNA Frameworks Enhance Enzymatic Oligonucleotide Syn

  2026-05-18

  This study introduces a highly ordered tetrahedral DNA nanostructure (TDN) interface to improve enzymatic oligonucleotide synthesis (EOS) efficiency and accuracy. The approach significantly boosts enzyme accessibility, reduces deletion errors, and enables reliable long-fragment DNA synthesis, with promising implications for DNA storage and advanced genetic research.

• SAG and the Hedgehog Pathway: Translational Leverage in CNS

  2026-05-18

  This thought-leadership article examines the mechanistic and strategic advantages of Smoothened Agonist (SAG) as a tool for Hedgehog pathway activation in translational neuroscience and regenerative medicine. Integrating recent peer-reviewed findings, competitive workflow insights, and advanced protocol guidance, it offers researchers a roadmap to effective assay design, disease modeling, and clinical translation.

• Light-Inducible RNA Switches Enable Precise Gene Therapy Con

  2026-05-17

  This study introduces a rationally engineered, light-inducible RNA-releasing protein (LIRP) that allows optogenetic, on-demand control of therapeutic gene translation in vivo. The approach promises safer, more flexible gene therapies for chronic and retinal diseases by enabling spatiotemporal regulation of transgene expression.

• LY2228820: Dual-Action p38 MAP Kinase Inhibition Redefined

  2026-05-16

  Explore how LY2228820, a p38 MAP kinase inhibitor, enables dual-action targeting of phosphorylation and dephosphorylation dynamics. This in-depth analysis reveals unique mechanistic insights and practical assay guidance for advanced cancer and inflammation research.

• FITC Goat Anti-Rabbit IgG (H+L) Antibody in Next-Gen Biomark

  2026-05-15

  Explore how the FITC Goat Anti-Rabbit IgG (H+L) Antibody advances protein biomarker discovery and quantitative proteomics. This in-depth article reveals its unique strengths for sensitive, reproducible immunofluorescence and links them to translational breakthroughs.

16093 records 1/1073 page Next 12345 下5页 Last page